BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 14,800 shares, an increase of 516.7% from the March 31st total of 2,400 shares. Based on an average daily trading volume, of 43,000 shares, the short-interest ratio is currently 0.3 days.

BetterLife Pharma Price Performance

BETRF remained flat at $0.07 during trading hours on Friday. BetterLife Pharma has a 52 week low of $0.03 and a 52 week high of $0.09. The company has a 50 day moving average price of $0.07 and a two-hundred day moving average price of $0.06. The company has a market capitalization of $8.18 million, a PE ratio of -3.60 and a beta of 1.39.

About BetterLife Pharma

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.